XML 84 R60.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Tax Expense (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Feb. 03, 2016
Operating Loss Carryforwards [Line Items]        
U.S. Federal statutory rate to net income (loss) before taxes 34.00%      
Deferred tax assets, valuation allowance $ 118,551 $ 133,784    
Change in valuation allowance (15,200)      
Net change in valuation allowance, recorded as tax expense (24,976) 35,678 $ 10,052  
Decrease in net operating loss carryforwards (101,423) (124,881)    
Decrease in research and development credits (16,079) (21,374)    
Undistributed earnings of foreign subsidiaries (100)      
Provision for income taxes $ (459) $ 498 $ (9,337)  
Effective tax rate 0.69%      
Provisional tax benefit, Tax reform act $ 400      
Internal Revenue Service (IRS)        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards, domestic 314,000      
Internal Revenue Service (IRS) | Research Tax Credit Carryforward        
Operating Loss Carryforwards [Line Items]        
Tax credit carryforward amount 9,400      
State and Local Jurisdiction        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards, state and local 173,000      
State and Local Jurisdiction | Research Tax Credit Carryforward        
Operating Loss Carryforwards [Line Items]        
Tax credit carryforward amount 14,300      
Income Tax Expense (Benefit)        
Operating Loss Carryforwards [Line Items]        
Net change in valuation allowance, recorded as tax expense (25,000)      
TriVascular Technologies, Inc. | Income Tax Expense (Benefit)        
Operating Loss Carryforwards [Line Items]        
Net change in valuation allowance, recorded as tax expense $ 9,800      
Scenario, Adjustment | TriVascular Technologies, Inc.        
Operating Loss Carryforwards [Line Items]        
Decrease in research and development credits       $ 3,100
Scenario, Adjustment | TriVascular Technologies, Inc. | State and Local Jurisdiction        
Operating Loss Carryforwards [Line Items]        
Decrease in net operating loss carryforwards       209,400
Scenario, Adjustment | TriVascular Technologies, Inc. | Domestic Tax Authority        
Operating Loss Carryforwards [Line Items]        
Decrease in net operating loss carryforwards       $ 230,300